Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Market Cap

Vanda Pharmaceuticals has a market cap or net worth of $408.44 million as of March 27, 2026. Its market cap has increased by 41.47% in one year.

• Market Cap: 408.44M
• Enterprise Value: 157.21M
• 1-Year Change: 41.47%
• Ranking: #3115
• Category: Small-Cap
• Stock Price: $6.91

Market Cap Chart

Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from $209.50M to $408.44M, an increase of 94.96%. That is a compound annual growth rate of 3.40%.

Market Cap History

Date	Market Cap	% Change
Mar 26, 2026	420.80M	-19.26%
Dec 31, 2025	521.20M	86.61%
Dec 31, 2024	279.30M	15.03%
Dec 29, 2023	242.80M	-41.94%
Dec 30, 2022	418.20M	-52.16%
Dec 31, 2021	874.10M	21.64%
Dec 31, 2020	718.60M	-17.90%
Dec 31, 2019	875.30M	-36.13%
Dec 31, 2018	1.37B	100.69%
Dec 29, 2017	682.90M	-2.57%
Dec 30, 2016	700.90M	75.84%
Dec 31, 2015	398.60M	-17.90%
Dec 31, 2014	485.50M	17.87%
Dec 31, 2013	411.90M	294.54%
Dec 31, 2012	104.40M	-21.97%
Dec 30, 2011	133.80M	-49.57%
Dec 31, 2010	265.30M	-13.30%
Dec 31, 2009	306.00M	2,200.75%
Dec 31, 2008	13.30M	-92.75%
Dec 31, 2007	183.40M	-66.04%
Dec 29, 2006	540.00M	157.76%
Apr 12, 2006	209.50M	-

View and export this data all the way back to 2006. Sign Up Today.

Related Stocks

Company	Market Cap
Absci	440.70M
Eupraxia Pharmaceuticals	436.23M
Invivyd	426.72M
REGENXBIO	426.32M
Atea Pharmaceuticals	424.65M
Aclaris Therapeutics	424.50M
Altimmune	416.22M
Neumora Therapeutics	416.05M